Loka vs. Provectus
Both firms appear in our cloud and data platform AI category. Here is how their scores, facts and best-fit buyers line up.
Updated October 2026
7.7
Healthcare, life sciences and AWS-native companies that need GenAI or ML moved from prototype to production.
Read the Loka review
7.9
AWS-centric enterprises in financial services or life sciences that need production ML, GenAI and data platform work with full IP transfer.
Read the Provectus reviewScores side by side
| Criterion | Loka | Provectus |
|---|---|---|
| Production track record | 8.4 | 8.2 |
| Technical depth | 8.0 | 8.4 |
| Industry depth | 8.0 | 7.8 |
| Delivery model and handoff | 7.6 | 8.3 |
| Commercial clarity | 6.4 | 7.9 |
| Platform independence | 6.2 | 6.4 |
| Stability and scale | 8.4 | 8.1 |
| Independent evidence | 8.0 | 7.2 |
| Overall | 7.7 | 7.9 |
Key facts
| Loka | Provectus | |
|---|---|---|
| Headquarters | Los Altos, California | San Francisco, California |
| Founded | 2004 | 2010 |
| Size | Not disclosed | 400+ AI builders (company-reported) |
| Pricing model | Not published | Milestone-based, outcome-linked contracts |
| Platform partners | AWS Premier Tier, Generative AI Competency | AWS (primary), GCP |
| Typical clients | Startups to enterprise | Enterprise |
Which to choose
Loka suits healthcare, life sciences and AWS-native companies that need GenAI or ML moved from prototype to production.
Provectus suits aWS-centric enterprises in financial services or life sciences that need production ML, GenAI and data platform work with full IP transfer.